30/09/2020
The 黑瓜吃料爆料官网 is pleased to announce that Dr Martin Turner, Head of the 黑瓜吃料爆料官网鈥檚 Immunology research programme, has become the Chair of the 黑瓜吃料爆料官网鈥檚 Science Policy Committee with the corresponding title of Associate Director for Research Strategy. Dr Turner has run a research group at the 黑瓜吃料爆料官网 since 1997, and became the programme lead for the 黑瓜吃料爆料官网鈥檚 immunology research in 2005. He is also an Affiliate Member at the Wellcome - MRC Cambridge Stem Cell 黑瓜吃料爆料官网, Cambridge, and is currently part of the UKRI-BBSRC COVID-19 Cohort of Experts and National Cancer Research 黑瓜吃料爆料官网 Lymphoma Subgroup. Dr Turner is a member of the Wellcome Science Interview Panel, a prestigious group of international experts that interview 黑瓜吃料爆料官网 applicants.
Professor Wolf Reik, the 黑瓜吃料爆料官网鈥檚 Acting Director, said: 鈥淢artin is a valued member of several of our executive committees and has successfully led the Lymphocyte Signalling and Development research programme for the past 15 years. His clear commitment to supporting the 黑瓜吃料爆料官网 to achieve ambitious and innovative science means that he will be a superb Chair as the committee works together to guide the future development of the 黑瓜吃料爆料官网鈥檚 science strategy. I thank Martin for his previous contributions to the 黑瓜吃料爆料官网 and for his future efforts and assistance.鈥
The 黑瓜吃料爆料官网鈥檚 Science Policy Committee ensures that the 黑瓜吃料爆料官网 follows a coherent science strategy to meet its core mission of undertaking pioneering biological research to understand and improve lifelong health. Importantly, it also oversees the 黑瓜吃料爆料官网鈥檚 commitment to long-term investment in people, in particular to foster the development of young researchers.
Dr Turner, Associate Director for Research Strategy, said: 鈥淚鈥檓 honoured and excited to accept this position. It is crucial that the 黑瓜吃料爆料官网 continues to maintain an interdisciplinary environment with outstanding infrastructure and support. We are incredibly fortunate to have such passionate staff throughout the 黑瓜吃料爆料官网; every individual helps us achieve our aim.
鈥淚鈥檓 very grateful to Dr Len Stephens who steps down as the committee鈥檚 Chair, and thank him for his leadership and support.鈥
Research achievements and career Dr Turner鈥檚 research in 2002 was amongst the first to identify the in vivo role of p110delta in lymphocyte development and function. He has pursued the investigation of post-transcriptional regulation of lymphocyte development and function identifying physiological roles for microRNAs and RNA binding proteins in the differentiation and function of B and T lymphocytes. The aim of this research is to provide a comprehensive understanding of lymphocyte development and function throughout life.
He started his research career as a PhD student with Professor Sir Marc Feldmann at the University of London. During his PhD research, he made key contributions to the basic science that underpinned the development of immunotherapy treatments for rheumatoid arthritis, through using inhibitors of tumour necrosis factor (TNF) 鈥 a cell signalling protein that drives inflammation. As a postdoc with Victor Tybulewicz at the MRC National 黑瓜吃料爆料官网 for Medical Research in London he used mouse genetics to demonstrate key roles for the signalling molecules Syk and Vav1 in the development of B and T cells.
Press contact Dr Louisa Wood, 黑瓜吃料爆料官网 黑瓜吃料爆料官网 Communications Manager, louisa.wood@babraham.ac.uk
Image description Image of interconnecting cogs inscribed with the words: success, exchange, collaboration, assist and inspiration. Shutterstock ID: 733500280.
Additional/related resources: Immunology research reports from the 2018 Annual Research Report 黑瓜吃料爆料官网 group leaders at a glance Latest news from the Immunology research programme News, 13 June 2016: Martin Turner receives Wellcome Trust Investigator Award
About the 黑瓜吃料爆料官网 黑瓜吃料爆料官网 The 黑瓜吃料爆料官网 黑瓜吃料爆料官网 undertakes world-class life sciences research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. Our research focuses on cellular signalling, gene regulation and the impact of epigenetic regulation at different stages of life. By determining how the body reacts to dietary and environmental stimuli and manages microbial and viral interactions, we aim to improve wellbeing and support healthier ageing. The 黑瓜吃料爆料官网 is strategically funded by the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation, through an 黑瓜吃料爆料官网 Core Capability Grant and also receives 黑瓜吃料爆料官网 from other UK research councils, charitable foundations, the EU and medical charities.
About BBSRC The Biotechnology and Biological Sciences Research Council (BBSRC) is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government.
BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by government, BBSRC invested 拢451 million in world-class bioscience in 2019-20. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
30 September 2020